Oslo, Norway, May 5, 2025 - The Board of Directors of Nykode Therapeutics ASA
(OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the
discovery and development of novel immunotherapies, hereby calls for the Annual
General Meeting to be held at meeting room FORUM - Building H, Floor 0 in
Gaustadalléen 21, Oslo, Norway at 10:00 CEST on May 26, 2025. 

All documents regarding the Annual General Meeting are available at the
Company's website: https://nykode.com/investors/shareholder-meetings/

For further information, please see the Company's website or contact the Company
at IR@nykode.com


This information is subject to the disclosure requirements pursuant to sections
5-12 of the Norwegian Securities Trading Act.